Ad
related to: pharmaceutical marketing definition
Search results
Results From The WOW.Com Content Network
Pharmaceutical marketing is a branch of marketing science and practice focused on the communication, differential positioning and commercialization of pharmaceutical products, like specialist drugs, biotech drugs and over-the-counter drugs.
Pharmaceutical companies shifted the focus of their marketing efforts to licensed medical doctors in the 1970s, as the FDA mandated that only doctors could prescribe medicine. [8] However, a larger movement towards autonomy in health care decisions prompted the first prominent examples of direct-to-consumer advertising.
Once a new active ingredient is authorised, any additional strengths, pharmaceutical forms, administration routes, presentations, as well as any variations (changes to the existing marketing authorisation) and extensions shall also be granted an authorisation or be included in the initial marketing authorisation, being subject of an abridged ...
Fraud in the pharmaceutical industry is more than an economic issue; it is a global health crisis. Governments, corporations, and organizations must unite to prioritize patient safety and ethical practices. Indian Pharma Network’s tireless efforts to make safe and affordable medicines accessible globally serve as a beacon of hope in this fight.
Pharmacocybernetics (also known as pharma-cybernetics, cybernetic pharmacy, and cyber pharmacy) is an emerging field that describes the science of supporting drugs and medications use through the application and evaluation of informatics and internet technologies, so as to improve the pharmaceutical care of patients.
Pharmaceutical Representative is a trade journal featuring common sales tactics such as how to close a tough sale by flattering a stubborn doctor. [9] Along with flattery, the attractiveness of sales reps has been noted, with a trend of former cheerleaders entering the field.
Marketing Authorisation Application (MAA) is an application submitted by a drug manufacturer seeking marketing authorisation, that is permission to bring a medicinal product (for example, a new medicine or generic medicine) to the market.
Postmarketing surveillance (PMS), also known as post market surveillance, is the practice of monitoring the safety of a pharmaceutical drug or medical device after it has been released on the market and is an important part of the science of pharmacovigilance.